Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2014 1
2016 2
2017 1
2018 3
2019 5
2020 8
2021 6
2022 3
2023 11
2024 11
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for okoye la
Search for Okode LA instead (1 results)
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Stratigos AJ, Sekulic A, Peris K, Bechter O, Prey S, Kaatz M, Lewis KD, Basset-Seguin N, Chang ALS, Dalle S, Orland AF, Licitra L, Robert C, Ulrich C, Hauschild A, Migden MR, Dummer R, Li S, Yoo SY, Mohan K, Coates E, Jankovic V, Fiaschi N, Okoye E, Bassukas ID, Loquai C, De Giorgi V, Eroglu Z, Gutzmer R, Ulrich J, Puig S, Seebach F, Thurston G, Weinreich DM, Yancopoulos GD, Lowy I, Bowler T, Fury MG. Stratigos AJ, et al. Lancet Oncol. 2021 Jun;22(6):848-857. doi: 10.1016/S1470-2045(21)00126-1. Epub 2021 May 14. Lancet Oncol. 2021. PMID: 34000246 Free article. Clinical Trial.
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
Stratigos AJ, Sekulic A, Peris K, Bechter O, Prey S, Lewis KD, Basset-Seguin N, Chang ALS, Dalle S, Fernández Orland A, Licitra L, Robert C, Ulrich C, Hauschild A, Migden MR, Dummer R, Yoo SY, Okoye E, Bassukas I, Loquai C, De Giorgi V, Eroglu Z, Gutzmer R, Ulrich J, Puig S, Inocencio TJ, Chen CI, LaFontaine PR, Seebach F, Lowy I, Fury MG. Stratigos AJ, et al. J Am Acad Dermatol. 2024 Feb;90(2):414-418. doi: 10.1016/j.jaad.2023.08.111. Epub 2023 Oct 14. J Am Acad Dermatol. 2024. PMID: 37839734 Free article. Clinical Trial. No abstract available.
Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022.
St Germain L, De Paula E, Ay C, Barco S, Cesarman-Maus G, Connors JM, Dumantepe M, Cecilia Guillermo Esposito M, Lee LH, Morishita E, Samama CM, Okoye H, Robertson T, McPherson G, Castellucci LA. St Germain L, et al. J Thromb Haemost. 2023 Sep;21(9):2311-2312. doi: 10.1016/j.jtha.2023.06.006. J Thromb Haemost. 2023. PMID: 37597893 Free article. No abstract available.
Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG).
Sudour-Bonnange H, van Tinteren H, Ramírez-Villar GL, Godzinski J, Irtan S, Gessler M, Chowdhury T, Audry G, Fuchs J, Powis M, van de Ven CP, Okoye B, Smeulders N, Vujanic GM, Verschuur A, L'Herminé-Coulomb A, de Camargo B, de Aguirre Neto JC, Schenk JP, van den Heuvel-Eibrink MM, Pritchard-Jones K, Graf N, Bergeron C, Furtwängler R. Sudour-Bonnange H, et al. Br J Cancer. 2024 Oct;131(6):972-981. doi: 10.1038/s41416-024-02799-0. Epub 2024 Jul 30. Br J Cancer. 2024. PMID: 39080350 Free PMC article. Clinical Trial.
Triple La Sota re-vaccinations can protect laying chickens for 3 months against drop in egg production caused by velogenic viscerotropic Newcastle disease virus infection.
Okechukwu HN, Chukwuedo AA, Eze DC, Igwe AO, Ihedioha JI, Okoye JOA. Okechukwu HN, et al. Vet Med Sci. 2020 Aug;6(3):470-476. doi: 10.1002/vms3.241. Epub 2020 Jan 29. Vet Med Sci. 2020. PMID: 31995272 Free PMC article.
One hundred and ten Isa Brown layers were vaccinated with La Sota, once at point of lay at 18 weeks and three times at peak of lay which occurred at 27-29 weeks of age. ...Based on the above observations, it is concluded that triple La Sota re-vaccination can protec …
One hundred and ten Isa Brown layers were vaccinated with La Sota, once at point of lay at 18 weeks and three times at peak of lay wh …
Effects of multiple La Sota vaccinations on the atrophy of the lymphoid organs associated with velogenic Newcastle disease virus infection in pullets.
Omeke JN, Onyema I, Ikenna-Eze HN, Ugochukwu IC, Eze DC, Ezema WS, Okoye JOA. Omeke JN, et al. Acta Vet Hung. 2025 Jul 11;73(3):159-166. doi: 10.1556/004.2025.01143. Print 2025 Sep 15. Acta Vet Hung. 2025. PMID: 40643972
This research evaluated the effects of multiple La Sota vaccinations on atrophy of the lymphoid organs associated with the velogenic Newcastle disease virus (vNDV) infection in pullets. Two hundred pullets were randomly assigned into five groups designated as unvaccinated …
This research evaluated the effects of multiple La Sota vaccinations on atrophy of the lymphoid organs associated with the velogenic …
Specimen Collection for Translational Studies in Hidradenitis Suppurativa.
Byrd AS, Dina Y, Okoh UJ, Quartey QQ, Carmona-Rivera C, Williams DW, Kerns ML, Miller RJ, Petukhova L, Naik HB, Barnes LA, Shipman WD, Caffrey JA, Sacks JM, Milner SM, Aliu O, Broderick KP, Kim D, Liu H, Dillen CA, Ahn R, Frew JW, Kaplan MJ, Kang S, Garza LA, Miller LS, Alavi A, Lowes MA, Okoye GA. Byrd AS, et al. Sci Rep. 2019 Aug 21;9(1):12207. doi: 10.1038/s41598-019-48226-w. Sci Rep. 2019. PMID: 31434914 Free PMC article.
A case of transdisciplinarity and collaborative decision making: the co-construction of Gendered Food Product Profiles.
Forsythe L, Olaosebikan O, Teeken B, Ngoh Newilah G, Mayanja S, Nanyonjo AR, Iragaba P, Okoye B, Marimo P, Kenneth A, Adinsi L, Kendine Vepowo C, Sounkoura A, Tinyiro SE, Bouniol A, Dufour D, Akissoé N, Madu T. Forsythe L, et al. J Sci Food Agric. 2024 Jun;104(8):4485-4497. doi: 10.1002/jsfa.13460. Epub 2024 Apr 3. J Sci Food Agric. 2024. PMID: 38483269 Review.
La Sota vaccination may not protect against virus shedding and the lesions of velogenic Newcastle disease in commercial turkeys.
Okoroafor O, Eze PC, Ezema WS, Nwosu C, Okorie-Kanu C, Animoke PC, Anene B, Okoye JOA. Okoroafor O, et al. Trop Anim Health Prod. 2018 Feb;50(2):345-351. doi: 10.1007/s11250-017-1439-9. Epub 2017 Oct 5. Trop Anim Health Prod. 2018. PMID: 28980209
The aim of this project is to study the clinical signs and lesion of velogenic Newcastle disease (vND) in commercial turkeys, and also to find out if La Sota vaccination offered protection against these signs and lesions. The cockerels were included as positive controls. . …
The aim of this project is to study the clinical signs and lesion of velogenic Newcastle disease (vND) in commercial turkeys, and also to fi …
42 results